1I.P.A.S. S.A., Via Mastri, Ligornetto, 6853, Switzerland.
This study addresses complex bioequivalence challenges, including high variability and endogenous substances, by recommending tailored protocols. Case-by-case analysis ensures adherence to guidelines for accurate drug assessment.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: